Literature DB >> 14640511

Antitumor agents. 228. five new agarofurans, Reissantins A-E, and cytotoxic principles from Reissantia buchananii.

Fang-Rong Chang1, Ken-Ichiro Hayashi, I-Hsiao Chen, Chih-Chuang Liaw, Kenneth F Bastow, Yuka Nakanishi, Hiroshi Nozaki, Gordon M Cragg, Yang-Chang Wu, Kuo-Hsiung Lee.   

Abstract

Twenty-one compounds, including five new agarofuran sesquiterpenes, reissantins A-E (1-5), were isolated from Reissantia buchananii by means of bioassay-directed fractionation and their structures identified from spectral data. Reissantins A-C are the first reported simple agarofuran sesquiterpenes to contain a 5-carboxy-N-methyl-2-pyridone (CNMP) substituent, which has previously been found only in macroring agarofuran pyridine alkaloids. The major terpenoid components, celastrol (6) and its methyl ester derivative, pristimerin (7), were significantly active against nine cancer cell lines, including A549, MCF-7, HCT-8, KB, KB-VIN, U-87-MG, PC-3, 1A9, and PTX10 cell lines, with ED(50) values ranging from 0.076 to 0.34 microg/mL.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14640511     DOI: 10.1021/np030241v

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  23 in total

Review 1.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

2.  Celastrol analogues as inducers of the heat shock response. Design and synthesis of affinity probes for the identification of protein targets.

Authors:  Lada Klaić; Richard I Morimoto; Richard B Silverman
Journal:  ACS Chem Biol       Date:  2012-03-14       Impact factor: 5.100

3.  Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones.

Authors:  Chunzhang Yang; Cody L Swallows; Chao Zhang; Jie Lu; Hongbin Xiao; Roscoe O Brady; Zhengping Zhuang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-18       Impact factor: 11.205

4.  Remarkable stereospecific conjugate additions to the Hsp90 inhibitor celastrol.

Authors:  Lada Klaić; Paul C Trippier; Rama K Mishra; Richard I Morimoto; Richard B Silverman
Journal:  J Am Chem Soc       Date:  2011-11-21       Impact factor: 15.419

5.  The triterpenoid pristimerin induces U87 glioma cell apoptosis through reactive oxygen species-mediated mitochondrial dysfunction.

Authors:  Yan-Yan Yan; Jian-Ping Bai; Yong Xie; Jie-Zhong Yu; Cun-Gen Ma
Journal:  Oncol Lett       Date:  2012-10-22       Impact factor: 2.967

6.  HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.

Authors:  Bin Peng; Limin Xu; Fanfan Cao; Tingxuan Wei; Chunxin Yang; Georges Uzan; Denghai Zhang
Journal:  Mol Cancer       Date:  2010-04-16       Impact factor: 27.401

Review 7.  Isoprenoids: remarkable diversity of form and function.

Authors:  Sarah A Holstein; Raymond J Hohl
Journal:  Lipids       Date:  2004-04       Impact factor: 1.880

8.  Personalized chemotherapy profiling using cancer cell lines from selectable mice.

Authors:  Hirohiko Kamiyama; Sherri Rauenzahn; Joong Sup Shim; Collins A Karikari; Georg Feldmann; Li Hua; Mihoko Kamiyama; F William Schuler; Ming-Tseh Lin; Robert M Beaty; Balasubramanyam Karanam; Hong Liang; Michael E Mullendore; Guanglan Mo; Manuel Hidalgo; Elizabeth Jaffee; Ralph H Hruban; H A Jinnah; Richard B S Roden; Antonio Jimeno; Jun O Liu; Anirban Maitra; James R Eshleman
Journal:  Clin Cancer Res       Date:  2013-01-22       Impact factor: 12.531

Review 9.  Natural compounds with proteasome inhibitory activity for cancer prevention and treatment.

Authors:  H Yang; K R Landis-Piwowar; D Chen; V Milacic; Q P Dou
Journal:  Curr Protein Pept Sci       Date:  2008-06       Impact factor: 3.272

10.  Pristimerin Induces Apoptosis in Prostate Cancer Cells by Down-regulating Bcl-2 through ROS-dependent Ubiquitin-proteasomal Degradation Pathway.

Authors:  Yong Bo Liu; Xiaohua Gao; Dorrah Deeb; Ali S Arbab; Subhash C Gautam
Journal:  J Carcinog Mutagen       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.